Aptargroup, Inc. Aktie News

AptarGroup, Inc. (ATR) Q4 2025 Earnings Call Transcript

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Reports Fourth Quarter and Annual 2025 Results.

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Declares Quarterly Dividend and Announces 2026 Annual Meeting Details.

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Again Recognized with Prestigious ‘A' Score on the CDP Climate Change Assessment.

AptarGroup, Inc. (ATR) Presents at 44th Annual J.P. Morgan Healthcare Conference Transcript

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Announces 2026 Quarterly Conference Call Dates.

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar to Present at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.

CRYSTAL LAKE, Ill.--(BUSINESS WIRE)--Aptar Group, Inc. (NYSE: ATR), a global leader in drug and consumer product dosing, dispensing and protection technologies, today announced that its Bidose (BDS) Liquid Nasal Spray System is the mechanism for delivering the newly approved CARDAMYST™ (etripamil) Nasal Spray. CARDAMYST received approval by the U.S. Food and Drug Administration (FDA) for the co...